External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factors.
Shunsuke KurodaShingo MatsumotoTakahide SanoTakeshi KitaiTaishi YonetsuShun KohsakaSho ToriiTakuya KishiIssei KomuroKen-Ichi HirataKoichi NodeYuya MatsuePublished in: BMJ open (2021)
The 4C Mortality Score performed well in an independent external COVID-19 cohort and may enable appropriate disposition of patients and allocation of medical resources.Trial registration number UMIN000040598.
Keyphrases
- risk factors
- end stage renal disease
- cardiovascular disease
- cardiovascular events
- coronavirus disease
- ejection fraction
- sars cov
- newly diagnosed
- healthcare
- chronic kidney disease
- clinical trial
- study protocol
- randomized controlled trial
- peritoneal dialysis
- metabolic syndrome
- coronary artery disease
- patient reported outcomes
- type diabetes
- phase iii
- phase ii
- cardiovascular risk factors